Price Alert

Merck & Co. Inc. (MRK)

NYSE: MRK · Real-Time Price · USD

84.54

1.78 (2.15%)

At close: Aug 15, 2025, 3:10 PM

Merck & Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	63.62B	63.92B	64.17B	63.17B	62.48B	61.4B	60.11B	59.31B	58.31B	57.87B	59.28B	58.97B	57.17B	53.98B	48.7B	47.7B	45.47B	43.42B
Cost of Revenue	14.88B	15.07B	15.19B	15.28B	15.46B	15.74B	16.13B	16.09B	15.77B	15.96B	17.41B	17.4B	16.92B	15.81B	13.63B	15.29B	14.85B	14.49B
Gross Profit	48.73B	48.85B	48.98B	47.9B	47.02B	45.66B	43.99B	43.22B	42.55B	41.91B	41.87B	41.57B	40.25B	38.17B	35.08B	32.41B	30.62B	28.93B
Operating Income	19.82B	20.4B	20.22B	14.16B	16.05B	4.91B	2.95B	8.15B	6.39B	16.47B	18.28B	18.54B	19.36B	15.99B	13.2B	7.51B	5.09B	5.83B
Interest Income	451M	451M	415M	339M	285M	325M	364M	389M	356M	262M	157M	71M	38M	32M	36M	38M	40M	45M
Pretax Income	19.16B	20.17B	19.94B	13.72B	15.25B	3.91B	1.89B	7.45B	5.41B	15.23B	16.44B	16.84B	18.52B	15.75B	13.88B	7.98B	5.42B	6.44B
Net Income	16.41B	17.43B	17.12B	12.15B	13.74B	2.31B	365M	4.61B	3.11B	13.03B	14.52B	15.26B	16.58B	14.18B	13.05B	7.2B	5.57B	7.03B
Selling & General & Admin	10.8B	10.89B	10.82B	10.76B	10.54B	10.51B	10.5B	10.39B	10.39B	10.2B	10.04B	10.19B	10B	9.77B	9.63B	9.89B	9.61B	9.42B
Research & Development	18.11B	17.57B	17.94B	22.98B	20.43B	30.25B	30.53B	24.68B	25.77B	15.25B	13.55B	12.84B	10.89B	12.41B	12.25B	15.02B	15.92B	13.68B
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	28.91B	28.45B	28.75B	33.74B	30.97B	40.76B	41.03B	35.07B	36.16B	25.45B	23.59B	23.03B	20.89B	22.18B	21.88B	24.9B	25.53B	23.1B
Interest Expense	1.28B	1.28B	1.27B	1.25B	1.24B	1.21B	1.15B	1.07B	998M	961M	962M	936M	888M	850M	807M	805M	812M	819M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	43.8B	43.52B	43.95B	49.02B	46.43B	56.49B	57.16B	51.16B	51.92B	41.4B	41B	40.43B	37.81B	37.99B	35.51B	40.19B	40.38B	37.59B
Income Tax Expense	2.74B	2.72B	2.8B	1.56B	1.5B	1.59B	1.51B	2.83B	2.29B	2.19B	1.92B	1.51B	1.87B	1.84B	1.52B	1.53B	1.22B	1.11B
Shares Outstanding (Basic)	2.51B	2.53B	2.54B	2.54B	2.53B	2.53B	2.55B	2.54B	2.54B	2.54B	2.54B	2.53B	2.53B	2.53B	2.53B	2.53B	2.53B	2.53B
Shares Outstanding (Diluted)	2.51B	2.53B	2.54B	2.54B	2.54B	2.54B	2.55B	2.55B	2.54B	2.55B	2.55B	2.54B	2.54B	2.54B	2.54B	2.54B	2.54B	2.54B
EPS (Basic)	6.48	6.87	6.74	4.79	5.42	0.92	0.15	1.82	1.23	5.14	5.73	6.03	6.56	5.61	5.17	2.85	2.20	2.78
EPS (Diluted)	6.50	6.88	6.74	4.77	5.39	0.90	0.14	1.80	1.22	5.12	5.71	6.01	6.53	5.59	5.14	2.84	2.20	2.77
EBITDA	25.04B	26.06B	25.71B	19.24B	20.58B	8.98B	6.91B	12.32B	10.15B	19.97B	21.32B	21.63B	23.06B	20.05B	17.9B	12.06B	9.56B	10.84B
EBIT	20.44B	21.45B	21.21B	14.97B	16.49B	5.12B	3.04B	8.52B	6.41B	16.19B	17.41B	17.78B	19.41B	16.6B	14.69B	8.78B	6.23B	7.26B
Depreciation & Amortization	4.6B	4.61B	4.5B	4.27B	4.09B	3.87B	3.87B	3.8B	3.75B	3.78B	3.91B	3.85B	3.65B	3.44B	3.21B	3.28B	3.33B	3.58B